Indian Army Department of Military Affairs Pharmaceutical Tender 2026 for Vaccines & Injections in India - 9 Items, 25% Quantity Option Clause

To bid on the Indian Army vaccines tender, ensure your company holds GST registration and PAN, submit technical and financial bids, and provide OEM authorizations if required. Confirm item specifications for each of the 9 listed medicines/injectables and comply with the 25% quantity variation clause and delivery-time formula.

Bidders must prepare GST certificate, PAN card, experience certificates for similar military medical supply projects, financial statements, and EMD documentation if applicable. Include technical compliance certificates and OEM authorizations to demonstrate supply capability and regulatory compliance for all 9 listed products.

Delivery terms permit a 25% quantity variation during and after contract award. The extended delivery time is calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days; delivery starts from the last date of the original delivery order.

The tender includes 9 items: Purified Vero Cell Rabies Vaccine; Pantoprazole 40 mg injection; Dicyclomine 20 mg/ml injection; Pheniramine Maleate 2.75 mg/ml injection; Silver Sulphadiazine ointment 20 gm; Typhoid polysaccharide 0.5 ml ampoule; Amiodarone 150 mg injection; Atropine Sulphate 0.6 mg/1 ml; Ondansetron 2 mg/ml, 4 ml.

The estimated value is ₹49,766. The EMD amount is not specified in the tender data; bidders should request explicit EMD/secure deposit requirements during bid clarification and include it in the financial bid only if mandated.

Although no explicit standards are listed, suppliers should confirm storage conditions (cold chain where required), shelf-life, and regulatory compliance for each product, including registration and licenses for medical injections listed in the 9-item BOQ.